FIELD: medicine.
SUBSTANCE: invention concerns application of polypeptide FGF-9 or its biologically active fragment to produce medical product for multiple sclerosis treatment. Polypeptide can be 94-95% identical to sequence from amino acid 1 to amino acid 208 of human FGF-9, presented on fig. 3 (SEQ ID NO: 5).
EFFECT: invention stimulates myelination, proliferation and persistency of oligodendrocyte neurons, improves nervous regeneration.
6 cl, 9 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PURIFIED IMMUNOGENIC PROTEIN, ITS FRAGMENTS AND DERIVATIVES | 1999 |
|
RU2304585C2 |
| METHODS FOR MAKING POLYCLONAL ANTIBODIES, ANTISERUM CONTAINING POLYCLONAL ANTIBODIES, AND METHODS FOR IMMUNISATION | 1999 |
|
RU2358982C2 |
| DNA-FRAGMENT ENCODING BRAIN NEUROTROPIC FACTOR (BDNF), BDNF PROTEIN AND METHOD OF ITS PREPARING | 1990 |
|
RU2131926C1 |
| ISOLATED DNA FRAGMENT, A METHOD OF PREPARING A RECOMBINANT PROTEIN EXHIBITING NEUROTROPIC ACTIVITY, PROTEIN NT-3 AND A PHARMACEUTICAL COMPOSITION | 1990 |
|
RU2128226C1 |
| ACTIVIN-ActRIIa-Fc ANTAGONISTS AND USE THEREOF FOR TREATING OR PREVENTING BREAST CANCER | 2008 |
|
RU2473362C2 |
| MODIFIED BIOSENSOR FOR DETECTING INTRACELLULAR PH | 2014 |
|
RU2603060C2 |
| DISEASE-RELATED PROTEIN | 2002 |
|
RU2384586C2 |
| ISOLATED NUCLEIC ACID ENCODING POLYPEPTIDE TAG 7, ISOLATED POLYPEPTIDE TAG 7, METHOD FOR INHIBITION OF TUMOR DEVELOPMENT IN MAMMALS (VARIANTS) AND METHOD FOR TREATMENT OF CANCER IN ANIMAL (VARIANTS) | 1998 |
|
RU2238976C2 |
| HUMAN ANTIBODIES AGAINST SEMAPHORIN 4D | 2018 |
|
RU2776443C2 |
| METHOD OF PRODUCING CELL CAPABLE TO PRODUCE HETEROPROTEINS WITH HIGH YIELD | 2008 |
|
RU2486245C2 |
